In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The present study investigated the utility of in vitro lipolysis performance indicators drug solubilization and maximum supersaturation ratio (SR(M)) for their predictive use for the in vivo performance in a minipig model. The commercial Lipanthyl formulation and a series of LbDDS based on identical self-nanoemulsifying drug delivery systems (SNEDDS) containing 200 mg of fenofibrate, either dissolved or suspended, were subjected to combined gastric (pH 2) and intestinal (pH 6.5) in vitro lipolysis. Based on the solubilization profiles and SRM the rank-order SNEDDS (75% drug load) > super-SNEDDS (150% drug load, dissolved) = SNEDDS suspension (150% drug load, partially suspended) > Lipanthyl was established, with an increased likelihood of drug precipitation above SR(M) > 3. The in vitro performance, however, was not reproduced in vivo in a minipig model as the mean plasma concentration over time curves of all LbDDS were comparable, independent of the initial physical state of the drug. There was no correlation between the area under the solubilization-time curves (AUC(in vitro)) of the intestinal step and the AUC(in vivo). The study suggests careful interpretation of in vitro performance criteria and revision of LbDDS optimization towards increased solubilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, the majority of studies reported in the literature comparing non-supersaturated and supersaturated LBDDS have used the same drug dose, which resulted in administration of less lipid volume in the case of sLBDDS (Siqueira et al., 2017; Michaelsen et al., 2016; Thomas et al., 2014).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Thomas et al., 2014
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, studies that have evaluated sLBDDS using the common lipolysis pH-stat in vitro methods, have failed to show the potential to improve in vivo performance using supersaturated systems relative to a non-supersaturated system (Thomas et al., 2014; Siqueira et al., 2017).”
From Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across PermeapadⓇ membrane and in vivo absorption (2020) · cites this paper as Thomas et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570 · cited 1×
“described previously (13,14); (3) SNEDDS suspension containing a saturated solution of fenofibrate in SNEDDS (corresponding to 100% fenofibrate solubility in SNEDDS)”
BackgroundPouton, C. W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00167-6 · Cited by 1,230 · cited 1×
“In LbDDS the drug is commonly dissolved in a single or, more frequently, a blend of excipients as in the case of selfnanoemulsifying drug delivery systems (SNEDDS) (6).”
BackgroundEnhancing intestinal drug solubilisation using lipid-based delivery systems
Porter, C. J. H., Pouton, C. W., Cuine, J. F., & Charman, W. N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.014 · Cited by 690 · cited 1×
“The delivery of the drug in the dissolved state is considered the major advantage of SNEDDS as the dissolution step of the crystalline material thereby is circumvented (8).”
BackgroundNano-emulsions and Micro-emulsions: Clarifications of the Critical Differences
Anton, N., & Vandamme, T. F. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0309-1 · Cited by 621
When poor solubility becomes an issue: From early stage to proof of concept
Stegemann, S., Leveiller, F., Franchi, D., de Jong, H., & Lindén, H. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.110 · Cited by 567 · cited 6×
“KEY WORDS: in vitro ipolysis; in vitro/in vivo correlation; lipids; SNEDDS suspensions; superSNEDDS; supersaturation.”
BackgroundMethodInfluentialCarriere, F., Barrowman, J. A., Verger, R., & René, L. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90908-u · Cited by 476
The utility of the minipig as an animal model in regulatory toxicology
Bode, G., Clausing, P., Gervais, F., Loegsted, J., Luft, J., Nogues, V., & Sims, J. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.05.009 · Cited by 396 · cited 2×
“It might be possible that in vivo fenofibrate precipitates in particles of similar size from all the investigated SNEDDS leading to similar drug absorption during the transit in the large gastrointestinal tract of the pig (33).”
BackgroundA dynamic in vitro lipolysis model
Zangenberg, N. H., Müllertz, A., Kristensen, H. G., & Hovgaard, L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00169-5 · Cited by 287
Self-citationWilliams, H. D., Sassene, P., Kleberg, K., Bakala-N'Goma, J.-C., Calderone, M., Jannin, V., Igonin, A., Partheil, A., Marchaud, D., Jule, E., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23205 · Cited by 274 · cited 1×
“Moreover, recent advances in the field have highlighted some critical factors during in vitro dispersion and in vitro digestion (16,17,28).”
BackgroundSelf-citationCharacterisation of drug release from cubosomes using the pressure ultrafiltration method
Boyd, B. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00262-x · Cited by 245 · cited 1×
“Physicochemical alternatives to cell culture models include phospholipid vesicle-based barriers (47) and ultrafiltration (48), which could also help to improve the prediction of the in vivo performance from in vitro digestion data and, ultimately, lead to a more rational development of SNEDDS.”
Background
Research works printed but not linked: 1
- Ren S, Ogbonna A, Koradia V, Sassene P, Rades T, Müllertz A. Redissolution and polymorph characterization of a poorly water-soluble drug precipitated during in vitro lipolysis from a lipid-based formulation. New Orleans, LA, USA: American Association of Pharmaceutical Sciencits (AAPS) Annual Meeting; 2010.
Cited by
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Dahan, A., Beig, A., Lindley, D., & Miller, J. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.018 · Cited by 200
Ditzinger, F., Price, D. J., Ilie, A.-R., Koehl, N. J., Janković, S., Τσακιρίδου, Γ., Aleandri, S., Kalantzi, L., Holm, R., Nair, A., et al. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12984 · Cited by 156
Self-citationVithani, K., Goyanes, Á., Jannin, V., Basit, A. W., Gaisford, S., & Boyd, B. J. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2639-y · Cited by 119
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems
Park, H., Ha, E., & Kim, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040365 · Cited by 127
“AUCs calculated as previously described and data replotted from [194].”
BackgroundMethod
Metadata
- Authors
- Thomas, N., Richter, K., Pedersen, T. B., Holm, R., Müllertz, A., & Rades, T.
- Affiliations
- University of Copenhagen (DK)
- Lundbeck (Denmark) (DK)
- Corresponding author
- Müllertz, Anette
- Venue
- The AAPS Journal
- Published
- 2014-04-02
- Volume
- 16
- Issue
- 3
- Pages
- 539-549
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC4012058
- OpenAlex
- W2017730149
- Semantic Scholar
- e11d5ed1960766d149960d3f048889c582dd4b0b
- Cited by
- 111
- References
- 48
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 2 · 2023: 9 · 2022: 6 · 2021: 6 · 2020: 22 · 2019: 11 · 2018: 11 · 2017: 7 · 2016: 12 · 2015: 13 · 2014: 3
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UniSA Research Outputs Repository (University of South Australia) (acceptedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- H. Lundbeck A/S
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- fenofibrate, lipid-based drug delivery, self-nanoemulsifying drug delivery system, in vitro lipolysis, solubilization, drug precipitation, minipig model, bioavailability prediction, drug solubility
- MeSH terms
- Animals, Hypolipidemic Agents, Chemistry, Pharmaceutical, Excipients, Gastric Mucosa, Intestinal Mucosa, Lipids, Lipolysis, Male, Fenofibrate, Suspensions, Swine, Swine, Miniature, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate. https://app.cochat.ai/papers/10.1208/s12248-014-9589-4
- The paper
- Thomas, N., Richter, K., Pedersen, T. B., Holm, R., Müllertz, A., & Rades, T. (2014). In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate. The AAPS Journal. https://doi.org/10.1208/s12248-014-9589-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.